AI-generated summary
The authors studied eight people, average age 62, with pressure ulcers on the sacrum or heel, treated with 660 nm low-level laser once daily for 12 sessions. They report that granulation tissue size improved by up to 50% on average, TNF gene expression decreased, and VEGF and TGF-β expression increased, while IL6 did not change significantly. The study had no control group, so the authors urge careful interpretation.
- Participants
- 8
- Who or what was studied
- Eight individuals with diabetes and degree III or IV sacroiliac or calcaneal pressure ulcers, mean age 62 years
- Wavelengths
- 660 nm
- Limits stated in the abstract
- Small sample of eight patients and no control group, so the authors caution that the promising results require careful analysis.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm
- Energy density (fluence)
- 2 J/cm2
- Power
- 100 mW
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Photobiomodulation, Low-level laser therapy, Control group. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.